Undifferentiated carcinoma of nasopharynx
MONDO:0021537A undifferentiated carcinoma that involves the nasopharynx.
Also known as: lymphoepithelioma of nasopharynx, lymphoepithelioma of the nasopharynx, nasopharyngeal lymphoepithelioma, nasopharyngeal nonkeratinizing undifferentiated carcinoma, nasopharyngeal undifferentiated carcinoma, nasopharynx undifferentiated carcinoma, undifferentiated carcinoma of the nasopharynx, undifferentiated nasopharyngeal throat cancer
2972 clinical trials for this condition and its sub-types, 7 tagged with Undifferentiated carcinoma of nasopharynx itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Could less radiation be just as good for nasopharyngeal cancer?
Disease control OngoingThis phase 3 trial is testing whether giving a lower dose of radiation to low-risk areas around the main tumor works as well as the standard higher dose for nasopharyngeal cancer. The study plans to enroll 700 people aged 18-70 with newly diagnosed, non-spreading cancer. The goal…
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Drug combo targets rare cancers in early trial
Disease control OngoingThis early-phase trial tests the combination of two drugs, vorinostat and azacitidine, in people with nasopharyngeal cancer or nasal NK-T cell lymphoma that has come back or spread. The main goal is to find the safest dose and see how the body responds. Only 18 participants are e…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Immunotherapy duo takes on rare tumors
Disease control OngoingThis phase 2 trial is testing a combination of two immunotherapy drugs, nivolumab and ipilimumab, in 798 people with over 50 types of rare cancers. The goal is to see if these drugs can shrink tumors by helping the immune system attack cancer cells. Participants receive the drugs…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Less neck radiation may be just as effective for nasopharyngeal cancer
Disease control OngoingThis study tests whether giving radiation to a smaller area of the neck is as good as the standard larger area for treating nasopharyngeal cancer that hasn't spread. About 474 adults with newly diagnosed cancer will be randomly assigned to one of two radiation plans. The goal is …
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC